On Cancer

Search by keywords:

Show search filters

Explore by tags:

862 Blog posts found

Slide Show

Puppy Love: Caring Canines Unleash Their Therapeutic Potential

Here we share with you a selection of photos featuring our favorite therapy dogs, Memorial Sloan Kettering’s Caring Canines.

Pictured: Ruby

In the News

Cancer Immunotherapy Named Science Magazine “Breakthrough of the Year”

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

Pictured: T cells

In Memoriam

Memorial Sloan Kettering Mourns the Death of Cancer Research Pioneer Janet Rowley

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.

Richard Barakat Appointed Deputy Physician-in-Chief for Memorial Sloan Kettering Regional Care Network and Alliances

Gynecological surgeon Richard Barakat will lead the network by expanding its presence in the New York metropolitan area while also building relationships and forming alliances with medical institutions outside the region.

Pictured: Richard R. Barakat,

Ask the Expert

Will I become addicted to the pain medications I may need during my cancer treatment?

Memorial Sloan Kettering physician Natalie Moryl discusses pain medications in cancer treatment and why patients should not avoid them due to fears of addiction.

Pictured: Natalie Moryl (Khojainova), MD


At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Pictured: Alexander Rudensky


When the Holiday Cheer Gets You Down: Eight Tips for Coping with Difficult Emotions

Clinical psychologist Wendy Lichtenthal offers advice to people with cancer and their loved ones, to whom "Happy Holidays" may ring hollow this year.

Pictured: Wendy Lichtenthal

In the Lab

Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell


Follow-Up Care Crucial for Pediatric Cancer Survivors

In this Q&A, pediatric endocrinologist Charles Sklar discusses Memorial Sloan Kettering’s Long-Term Follow-Up Program, which manages the health of pediatric cancer survivors.

Pictured: Charles Sklar

In the Clinic

New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Ross Levine